Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time-Reference-Cited by-同舟云学术

Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time

Published:2016-07-12 Issue:6 Volume:26 Page:408-434
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Rev. Med. Virol.

Author:

Cuypers Lize¹,Ceccherini-Silberstein Francesca²,Van Laethem Kristel¹,Li Guangdi¹³,Vandamme Anne-Mieke¹⁴,Rockstroh Jürgen Kurt⁵

Affiliation:

1. KU Leuven - University of Leuven; Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology; Leuven Belgium

2. Department of Experimental Medicine and Surgery; University of Rome Tor Vergata; Rome Italy

3. Department of Metabolism and Endocrinology, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, National Clinical Research Center for Metabolic Diseases; The Second Xiangya Hospital, Central South University; Changsha Hunan China

4. Center for Global Health and Tropical Medicine, Microbiology Unit; Institute for Hygiene and Tropical Medicine, University Nova de Lisboa; Lisbon Portugal

5. Department of Medicine I; University Hospital Bonn; Bonn Germany

Funder

Fonds Wetenschappelijk Onderzoek

National Nature Science Foundation of China

Project of Innovation-driven Plan of Central South University

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference180 articles.

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome;Choo;Science,1989

2. The global burden of disease attributable to contaminated injections given in health care settings;Hauri;International Journal of STD and AIDS,2004